Last reviewed · How we verify
Does Liposomal Bupivacaine Improve Postoperative Pain Control After One Level Posterior Spinal Fusion With Instrumentation
This study will describe postoperative pain management for spine surgery patients receiving liposomal bupivacaine (Exparel®) compared to patients not receiving the drug.
Details
| Lead sponsor | Allina Health System |
|---|---|
| Phase | Phase 4 |
| Status | SUSPENDED |
| Enrolment | 60 |
| Start date | 2019-01-26 |
| Completion | 2028-08 |
Conditions
- Lumbar Spinal Stenosis
- Lumbar Disc Herniation
- Lumbar Disc Disease
- Lumbar Spondylolisthesis
Interventions
- Liposomal bupivacaine
Primary outcomes
- Change in Visual Analog Pain Scores — Through study completion, an average of 2.5 days
Change in Visual Analog Pain Scores over time; respondents report pain at incision site and at drain site on a scale of No pain (0) to Intolerable pain (10).
Countries
United States